✦ LIBER ✦

Resistance of human H2 glioblastoma cell to complement-mediated killing

✍ Scribed by S. Junnikkala; V. Koistinen; S. Meri

Book ID: 117326336
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 316 KB
Volume: 35
Category: Article
ISSN: 0161-5890
DOI: 10.1016/s0161-5890(98)90653-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanism of bacterial resistance to com

Mechanism of bacterial resistance to complement-mediated killing

✍ K.A. Joiner; C.H. Hammer; E.J. Brown; M.M. Frank 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 127 KB

The human lymphokine leukoregulin induce

The human lymphokine leukoregulin induces cell resistance to complement-mediated lysis

✍ Zvi Fishelson; Shimon Shlanger; Yonit Bomstein; Charles H. Evans 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 562 KB

Structural studies of ail-mediated resis

Structural studies of ail-mediated resistance of E. coli to killing by complement

✍ V. Rossi; L.D. Tatar; K.B. Beer; V.L. Miller; A.F. Esser 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Human pathogenic Borrelia spielmanii sp.

Human pathogenic Borrelia spielmanii sp. nov. resist complement-mediated killing by binding of immune regulators factor H and FHL-1

✍ Pia Herzberger; Corinna Siegel; Christine Skerka; Volker Fingerle; Ulrike Schult 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 71 KB

White blood cells including polymorphonu

White blood cells including polymorphonuclear phagocytes contain a factor which induces gonococcal resistance to complement-mediated serum killing

✍ P.V. Patel; N.J. Parsons; J.R.C. Andrade; C.A. Nairn; E.L. Tan; M. Goldner; J.A. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

Role of target antigen in bispecific-ant

Role of target antigen in bispecific-antibody-mediated killing of human glioblastoma cells: A pre-clinical study

✍ Achim Pfosser; Martina Brandl; Helmut Salih; Ludger Grosse-Hovest; Gundram Jung 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 85 KB 👁 1 views

Bispecific antibodies (bsAbs) directed to tumor-associated antigens and to receptors mediating T-cell activation, such as the TCR/CD3 complex and the co-stimulatory CD28 molecule, are capable of activating T cells at the surface of tumor cells, resulting in tumor-cell killing. Here we report the pre